Down‐regulation of Bcl‐2 and Bcl‐xL expression with bispecific antisense treatment in glioblastoma cell lines induce cell death

Zhihong Jiang,Xiao Zheng,K. Rich

DOI: https://doi.org/10.1046/j.1471-4159.2003.01522.x

2003-01-01

Journal of Neurochemistry

Abstract:The functions of the antiapoptotic proteins Bcl‐2 and Bcl‐xL were examined in glioblastoma cells. Expression of both Bcl‐2 and Bcl‐xL were found to be elevated in protein lysates from seven early passage cell lines derived from human glioblastoma tumors compared with non‐neoplastic glial cells. Down‐regulation of both bcl‐2 and bcl‐xL expression in glioblastoma cell lines U87 and NS008 with bcl‐2/bcl‐xL bispecific antisense oligonucleotide resulted in spontaneous cell death. The mechanism of cell death was partially caspase‐dependent. Executioner caspase 6 and caspase 7, but not caspase 3, were involved in apoptosis induced by bcl‐2/bcl‐xL antisense treatment. Interestingly, western blots failed to demonstrate expression of caspase 3 in two of the seven glioblastoma cell lines examined. The data support the hypothesis that Bcl‐2 and Bcl‐xL are important in preventing cell death in glioblastoma cells. It also suggests that there are functional pathways capable of successful completion of caspase‐dependent cell death in gliomas. These findings support a potential role of bcl‐2/bcl‐xL bispecifc antisense oligonucleotide therapy as a treatment strategy to enhance caspase‐dependent cell death in patients with glioblastoma.